# FDA Inspection 1182021 - Bridgeport Hospital Blood Bank - October 19, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/bridgeport-hospital-blood-bank/f7c74bff-846d-4f92-bb15-49b22bef88f9/
Source feed: FDA_Inspections

> FDA Inspection 1182021 for Bridgeport Hospital Blood Bank on October 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182021
- Company Name: Bridgeport Hospital Blood Bank
- Inspection Date: 2022-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1182021 - 2022-10-19](https://www.globalkeysolutions.net/api/records/fda_inspections/bridgeport-hospital-blood-bank/9b08ca46-b89e-4c5f-ab7b-aef0a4b23b7f/)
- [FDA Inspection 829346 - 2013-04-29](https://www.globalkeysolutions.net/api/records/fda_inspections/bridgeport-hospital-blood-bank/ad9722fb-1bd8-47c5-b604-227abed20d39/)
- [FDA Inspection 719422 - 2011-04-13](https://www.globalkeysolutions.net/api/records/fda_inspections/bridgeport-hospital-blood-bank/f4fafa2e-fc95-43b0-a510-c104fb789fb9/)
- [FDA Inspection 595807 - 2009-07-10](https://www.globalkeysolutions.net/api/records/fda_inspections/bridgeport-hospital-blood-bank/6ff308e9-405c-4d81-90a4-32fc2ff61309/)

Company: https://www.globalkeysolutions.net/companies/bridgeport-hospital-blood-bank/23059c14-b4a5-41b9-8795-1f3b533d6b89

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d